Mathematical Modeling, Analysis, and Simulation to Accelerate and De-risk Therapeutic R&D

Fit-for-purpose model

"We chose Applied BioMath for our project because their past work with us has proven that they are the leader in applying QSP approaches in drug development. "
Michael Kavanaugh, MD - CytomX Therapeutics
>160

Collaborations

>55

Partner Companies

$4.7M

NIH and FDA Grant Funding

Many reasons to choose Applied BioMath

Learn About Us >>

What Our Scientific Partners Are Saying

Working with Applied BioMath enabled us to foresee any hurdles we may have encountered and also ensured we are structuring our trials such that we are targeting the right patients and the right doses.


Mark Currie, PhD
Ironwood Pharmaceuticals

We chose to work with Applied BioMath because of their significant expertise and strength in developing mechanistic QSP models in oncology.


Karim Azer, PhD
Sanofi

Applied BioMath delivered exactly what we asked for in the time frame agreed upfront. Josh and John worked with the team to leverage both internal and external information and develop a fit-for-purpose model in an eight-week time frame. 


Anne Heatherington, PhD
Pfizer